Bod Australia Ltd (AU:BOD) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Bod Science Limited has announced a deferral of its Annual General Meeting and financial reporting obligations due to its external administration status. The company, which focuses on cannabis-based drug development, will rely on regulatory relief to delay these requirements for up to 24 months. Investors are advised to monitor the situation as BOD navigates this period of financial restructuring.
For further insights into AU:BOD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue